CreditReports.dk
HomeScreen companies

XGX Pharma ApS Financials, key figures and credit report

CVR number: 32289290 Established 2009 Industry: 46 Wholesale trade
Company contact details
Frederiksgade 11, 1265 København K msa@vitalpharmanordic.com tel: 70276627
Gross profit 32 338.4 kDKK FY 2025 +101.7% vs 2024
EBIT 21 199.2 kDKK FY 2025 +224.3% vs 2024
Net debt 5 119.0 kDKK FY 2025 -19.1% vs 2024
Quick ratio 1.4 FY 2025 +0.1 vs 2024

Company information

Official name
XGX Pharma ApS
Personnel
5 persons
Established
2009
Company form
Private limited company
Industry

Data sources and methodology

The information about XGX Pharma ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About XGX Pharma ApS

XGX Pharma ApS (CVR number: 3228929-0) is a company from KØBENHAVN. The company recorded a gross profit of 32.3 mDKK in 2025. The operating profit was 21.2 mDKK, while net earnings were 16.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was 45.4 %, which can be considered excellent and Return on Equity (ROE) was 64.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 55.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. XGX Pharma ApS's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit14 515.292 917.688 100.8216 033.7932 338.38
EBIT9 072.84-2 289.951 476.266 536.7321 199.15
Net earnings7 248.51-1 842.55460.894 453.4316 074.12
Shareholders equity total13 168.8713 798.7414 259.6318 713.0630 787.18
Balance sheet total (assets)21 257.4127 639.6829 601.2039 006.2055 114.89
Net debt1 948.017 704.447 648.626 325.435 119.01
Profitability
EBIT-%
ROA39.9 %-9.0 %4.9 %18.9 %45.4 %
ROE55.6 %-13.7 %3.3 %27.0 %64.9 %
ROI53.9 %-10.8 %5.9 %25.1 %62.9 %
Economic value added (EVA)6 501.12-2 482.05-28.603 950.8215 172.13
Solvency
Equity ratio61.9 %51.3 %48.2 %48.0 %55.9 %
Gearing14.8 %55.8 %53.6 %33.8 %16.6 %
Relative net indebtedness %
Liquidity
Quick ratio1.82.41.21.31.4
Current ratio2.52.71.61.51.7
Cash and cash equivalents
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
45.4%
Rating 92/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
55.9%
Rating 44/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of XGX Pharma ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated